Here’s a detailed and well-organized table based on the content you provided:
Category | Details |
---|---|
中文 | |
Contact Us | |
search | |
nav | |
Home+ | |
About NMPA+ | |
Leadership | |
Our Responsibilities | |
NMPA Organizations | |
Affiliated Institutions | |
Contact Us | |
News+ | |
Drugs+ | |
Medical Devices+ | |
Cosmetics+ | |
Resources+ | |
Database | |
Worldwide Pharmacopoeia | |
Newsletter | |
Popular Science | |
Links | |
World Health Organization | |
State Council of the PRC | |
National Institutes for Food and Drug Control | |
Chinese Pharmacopoeia Commission | |
Center for Drug Evaluation of NMPA | |
Center for Food and Drug Inspection of NMPA | |
Center for Drug Reevaluation of NMPA | |
Center for Medical Device Evaluation of NMPA | |
Center for Administrative Services and Complaints & Reports of NMPA | |
Center for Administration Service of NMPA | |
Information Center of NMPA | |
NMPA Institute of Executive Development | |
Certification Center for Licensed Pharmacist of NMPA | |
News and Publicity Center of NMPA | |
China Health-Media Group | |
China Center for Food and Drug International Exchange | |
NMPA Southern Medicine Economic Research Institute | |
146 Warehouse of NMPA | |
Chinese Pharmaceutical Association | |
Yangtze River Delta Center for Drug Evaluation and Inspection of NMPA | |
Yangtze River Delta Center for Medical Device Evaluation and Inspection of NMPA | |
Guangdong-Hong Kong-Macao Greater Bay Area Center for Drug Evaluation and Inspection of NMPA | |
Guangdong-Hong Kong-Macao Greater Bay Area Center for Medical Device Evaluation and Inspection of NMPA | |
Beijing | |
Tianjin | |
Hebei | |
Shanxi | |
Inner Mongolia | |
Liaoning | |
Jilin | |
Heilongjiang | |
Shanghai | |
Jiangsu | |
Zhejiang | |
Anhui | |
Fujian | |
Jiangxi | |
Shandong | |
Henan | |
Hubei | |
Hunan | |
Guangdong | |
Guangxi | |
Hainan | |
Chongqing | |
Sichuan | |
Guizhou | |
Yunnan | |
Tibet | |
Shaanxi | |
Gansu | |
Qinghai | |
Ningxia | |
Xinjiang | |
News | |
China establishes national working group to standardize healthcare security | |
China to deepen medical, healthcare reform in 2024 | |
China’s action on rare diseases inspires hope among patients | |
Laws & Regulations | |
Provisions for Medical Device Registration and Filing | |
Provisi |
Feel free to use this table as needed!
-
域名信息
注册人/机构:国家药品监督管理局
注册人邮箱:***ngjm@cfda.gov.cn
域名年龄:6年4天(过期时间为2027年07月03日)
-
备案信息
备案号:京ICP备13027807号
名称:国家药品监督管理局
性质:政府机关
审核时间:2024-03-27
-
网站信息
IP:58.215.155.223[中国江苏无锡 电信]
数据统计
数据评估
关于National Medical Products Administration特别声明
本站血鸟导航提供的National Medical Products Administration相关数据内容都来源于网络或站长收集,不保证外部链接和内容的准确性和完整性,同时,对于该外部链接的指向,不由血鸟导航实际控制,在2024年8月6日 上午10:03收录时,该网页上的内容,都属于合规合法,后期网页的内容如出现违规或不对称,欢迎联系我们邮箱进行删除或更改,血鸟导航不承担任何责任。
相关导航
暂无评论...